Your browser doesn't support javascript.
loading
Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial.
Hofmann, Daniela; Sayasone, Somphou; Sengngam, Khanpaseuth; Chongvilay, Bounthunh; Hattendorf, Jan; Keiser, Jennifer.
Affiliation
  • Hofmann D; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Sayasone S; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland; Lao Tropical and Public Health Institute, Vientiane, Laos.
  • Sengngam K; Lao Tropical and Public Health Institute, Vientiane, Laos.
  • Chongvilay B; Lao Tropical and Public Health Institute, Vientiane, Laos.
  • Hattendorf J; Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland.
  • Keiser J; Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland; University of Basel, Basel, Switzerland. Electronic address: jennifer.keiser@swisstph.ch.
Lancet Infect Dis ; 21(8): 1151-1160, 2021 08.
Article in En | MEDLINE | ID: mdl-33798487

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Strongyloidiasis / Strongyloides stercoralis / Macrolides / Anthelmintics Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Animals / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Strongyloidiasis / Strongyloides stercoralis / Macrolides / Anthelmintics Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Animals / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Lancet Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: Suiza Country of publication: Estados Unidos